Metraipolis › archive › dc_ade191318e2c

Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis — Europe PMC PMID:42278652

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42278652
DOI
10.3390/ijms27115129
License (as archived)
solo-consultazione
Archived
2026-10-31T17:27:54.523Z
SHA-256 of the archived text
b199b538ecde63d1740d41c9b5bfd2a53d0a9d480aae9ba0afb56500c0568172
Stable URL of this page
https://metraipolis.com/documento/dc_ade191318e2c

How to cite

Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis — Europe PMC PMID:42278652 — Europe PMC (en), https://europepmc.org/article/MED/42278652 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_ade191318e2c (Metraipolis archive dc_ade191318e2c, sha256 b199b538ecde63d1740d41c9b5bfd2a53d0a9d480aae9ba0afb56500c0568172)
BibTeX
@misc{dcade191318e2c,
  title = {Exploratory FDG PET/CT Imaging in mCRPC Patients Treated with Sipuleucel-T ± IL-7: A Phase II Trial Subanalysis — Europe PMC PMID:42278652},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42278652},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_ade191318e2c; sha256 b199b538ecde63d1740d41c9b5bfd2a53d0a9d480aae9ba0afb56500c0568172},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42278652. Agents can read the archived copy with the MCP tool read_document.